ReNeuron to press on with stem cell therapy for disabled stroke patients
This article was originally published in Scrip
Executive Summary
ReNeuron has raised approximately £4.7 million to fund Phase I clinical trials of ReN001, its stem cell therapy for disabled stroke patients.